Live feed
Filing
SCHEDULE 13D
SCHEDULE 13D0000950170-25-093838·LIGAND PHARMACEUTICALS INC
Schedule 13D ownership disclosure
PELTHOS THERAPEUTICS INC
Common Stock, par value $0.0001 per share · CUSIP: 171126204
Event date: 2025-07-01
- Filing-level shares
- 4,927,868
- Percent of class
- 49.9%
- Ligand Pharmaceuticals IncorporatedReported CIK 0000886163
Shares: 4,927,868 · Class: 49.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-093838
- Form type
- SCHEDULE 13D
- Filer
- LIGAND PHARMACEUTICALS INC
- CIK
- CIK 886163
- Filed
- Jul 03, 2025
- Reporting period
- Jul 01, 2025
- Description
- Schedule 13D beneficial ownership